Therapeutic potential of pluripotent stem cell-derived dopaminergic progenitors in Parkinson’s disease: a systematic review protocol
Abstract Background Parkinson’s disease (PD) is the second most common age-dependent neurodegenerative disease that causes motor and cognitive disabilities. This disease is associated with a loss of dopamine content within the putamen, which stems from the degeneration of dopaminergic (DA) neurons i...
Main Authors: | Aliasghar Karimi, Mitra Elmi, Zahra Shiri, Hossein Baharvand |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-06-01
|
Series: | Systematic Reviews |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13643-021-01736-z |
Similar Items
-
Mechanisms of Dopaminergic Neurodegeneration in Parkinson's Disease
by: Verma, Aditi
Published: (2018) -
Cryopreservation of Human Midbrain Dopaminergic Neural Progenitor Cells Poised for Neuronal Differentiation
by: Nicola J. Drummond, et al.
Published: (2020-11-01) -
Dopaminergic Progenitors Derived From Epiblast Stem Cells Function Similarly to Primary VM-Derived Progenitors When Transplanted Into a Parkinson’s Disease Model
by: Sophie V. Precious, et al.
Published: (2020-04-01) -
Nigral dopaminergic neuron replenishment in adult mice through VE-cadherin-expressing neural progenitor cells
by: Abir A Rahman, et al.
Published: (2017-01-01) -
Celastrol Inhibits Dopaminergic Neuronal Death of Parkinson’s Disease through Activating Mitophagy
by: Ming-Wei Lin, et al.
Published: (2019-12-01)